Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...

In a phase 1b/2a trial subcutaneous amycretin demonstrated a safety profile similar to other incretin-based drugs . Adults ...

Novo Nordisk announces positive results from phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity: Bagsværd, Denmark Monday, January 27, 2025, 13:00 ...

On Friday, the Danish pharma giant released the stellar results from a phase 1/2 trial for a once-weekly jab in its pipeline.

Over the past six months, a number of stores in the capital area that sell alcohol, nicotine or tobacco have been visited by young secret shoppers from Sikkerhedsstyrelsen (the Danish Safety Authority ...

A flurry of fresh weather warnings for snow, wind and rain have been issued for Sunday as Storm Eowyn continues to batter the UK and Ireland. Flights were cancelled, major rail routes closed and ferry ...